Impact of KEAP1/NFE2L2 Mutations on Local Recurrence in Patients Receiving Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases

被引：0
|
作者：
Chen, M. S. [1 ]
Carpenter, D. J. [2 ]
Leng, J. X. [1 ]
Qazi, J. J. [1 ]
Wan, Z. [3 ]
Niedzwiecki, D. [3 ]
Alder, L. R. [4 ]
Clarke, J. [4 ]
Kirkpatrick, J. P. [1 ,5 ]
Floyd, S. R. [1 ]
Reitman, Z. J. [1 ]
Mullikin, T. C. [1 ]
机构：
[1] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA
[2] Wellstar Paulding Hosp, Hiram, GA USA
[3] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA
[4] Duke Univ, Med Ctr, Dept Med Oncol, Durham, NC USA
[5] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2498
引用
收藏
页码：E223 / E223
页数：1
相关论文
共 50 条
  • [31] Genomic alterations of KEAP1/NFE2L2/CUL3(K/N/C) in Chinese lung cancer patients (pts)
    Qian, C.
    Wang, C.
    Wang, X.
    He, Q.
    Ma, T.
    Zhang, X.
    ANNALS OF ONCOLOGY, 2020, 31 : S1118 - S1118
  • [32] Outcome of Stereotactic Radiosurgery for Patients with Non-Small Cell Lung Cancer Metastatic to The Brain
    Mariya, Yasushi
    Sekizawa, Genichirou
    Matsuoka, Yoshisuke
    Seki, Hirobumi
    Sugawara, Takayuki
    JOURNAL OF RADIATION RESEARCH, 2010, 51 (03) : 333 - 342
  • [33] Systemic Therapy as a Prognosticator in Patients Receiving Stereotactic Radiosurgery for Non-Small Cell Lung Cancer
    Wandrey, N.
    Pawlowski, J.
    Seddo, F.
    Crownover, R. L.
    Fakhreddine, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 243 - 244
  • [34] Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
    Paik, Paul K.
    Fan, Pang-Dian
    Qeriqi, Besnik
    Namakydoust, Azadeh
    Daly, Bobby
    Ahn, Linda
    Kim, Rachel
    Plodkowski, Andrew
    Ni, Ai
    Chang, Jason
    Fanaroff, Rachel
    Ladanyi, Marc
    de Stanchina, Elisa
    Rudin, Charles M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : 516 - 526
  • [35] Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228.
    Paik, Paul K.
    Ahn, Linda Su Hyun
    Ginsberg, Michelle S.
    Plodkowski, Andrew J.
    Kim, Rachel
    Doyle, L. Austin
    Rudin, Charles M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [36] KEAP1/NFE2L2 Transcriptomic Signature Predicts Survival in Advanced Stage NSCLC Patients Without Actionable Driver Mutations
    Scheffler, M.
    Dugan, M.
    Saleh, M. M.
    Koleczko, S.
    Bragelmann, J.
    Arolt, C.
    Nogova, L.
    Riedel, R.
    Michels, S.
    Eisert, A.
    Fischer, R.
    Scharpenseel, H.
    Weber, J. P.
    Scheel, A. H.
    Merkelbach-Bruse, S.
    Buttner, R.
    Lafleur, F.
    Wild, R.
    Catanzariti, L.
    Hillmer, A. M.
    Wolf, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S451 - S452
  • [37] DISTANT BRAIN FAILURE FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
    Keller, Andrew
    All, Sean
    Patel, Hanisha
    Nguyen, Steven
    Pearson, Luke
    Ramakrishna, Naren
    NEURO-ONCOLOGY, 2018, 20 : 56 - 56
  • [38] Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
    Arolt, Christoph
    Scheel, Andreas H.
    Dugan, Margaret
    Wild, Robert
    Richartz, Vanessa
    Holz, Barbara
    Braegelmann, Johannes
    Wagener-Ryczek, Svenja
    Merkelbach-Bruse, Sabine
    Wolf, Juergen
    Buettner, Reinhard
    Catanzariti, Luigi
    Scheffler, Matthias
    Hillmer, Axel M.
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [39] Benchmark of screening markers for KEAP1/NFE2L2 mutations and joint analysis with the K1N2-score
    Arolt, Christoph
    Calaminus, Andreas
    Dugan, Margaret
    Wild, Robert
    Richartz, Vanessa
    Holz, Barbara
    Braegelmann, Johannes
    Wagener-Ryczek, Svenja
    Merkelbach-Bruse, Sabine
    Wolf, Juergen
    Buettner, Reinhard
    Catanzariti, Luigi
    Scheffler, Matthias
    Hillmer, Axel
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 134 - 134
  • [40] Investigating gene expression profiles associated with clinical radiation resistance in KEAP1/NFE2L2 wildtype lung cancer.
    Binkley, Michael S.
    Jeon, Young-Jun
    Nesselbush, Monica
    Moding, Everett J.
    Nabet, Barzin
    Almanza, Diego
    Yoo, Christopher
    Kurtz, David M.
    Owen, Susie Grant
    Backhus, Leah M.
    Berry, Mark F.
    Shrager, Joseph B.
    Ramchandran, Kavitha J.
    Padda, Sukhmani K.
    Das, Millie
    Neal, Joel W.
    Wakelee, Heather A.
    Alizadeh, Ash A.
    Loo, Billy W.
    Diehn, Maximilian
    CLINICAL CANCER RESEARCH, 2021, 27 (08)
12345